The Centre on Thursday stepped up the measures to increase production, supply and reduce prices of Remdesivir in the country.
As part of the measure, Minister of State, For Ports, Shipping and Chemicals& Fertilizers Mansukh Mandaviya held a meeting with the all-existing manufacturers of the Remdesivir drug and other stakeholders where decisions have been taken to.
The current total installed capacity of the seven manufacturers of Remdesivir is 38.80 lakh vials per month. Fast-track approval has been given for seven additional sites having the production capacity of 10 Lakh vials /month to six manufacturers. Another 30 lakh vials/month production is lined up. This would ramp up the production capacity for manufacturing to around 78 lakh vials/month.
As an additional measure, Remdesivir, API and formulation were placed under the Export ban on April 11, 2021, by DGFT to increase the supply of Remdesivir in the Domestic Market. On Government intervention, Remdesivir supplies of approximately 4 lakh vials meant for Export is being diverted by manufacturers to fulfil the domestic requirement.
Manufacturers of Remdesivir have volunteered to reduce the price to less than Rs 3500 by the end of this week, to support the efforts of Prime Minister Narendra Modi, to Fight against COVID,
Manufactures of Remdesivir have also been directed to give priority to fulfil hospital, institutional level supplies. Enforcement Authorities of States and Central Govt. have been directed by DCGI to take immediate action on the incidence of black-marketing, hoarding and overcharging of Remdesivir.
National Pharmaceutical Pricing Authority (NPPA) is continuously monitoring the availability of Remdesivir.